Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
TELA Bio, Inc. develops innovative soft-tissue reconstruction solutions, primarily through its OviTex portfolio, which combines biologic matrices with polymer reinforcement for hernia repair and plastic surgery. Its products aim to improve clinical outcomes, reduce complications, and lower costs. The company partners with healthcare providers, leverages extensive clinical data, and holds proprietary IP to address unmet needs in tissue repair markets worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.